Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription Articles published in Radiology Retrieve available abstracts of 128 articles: HTML format

Single Articles

June 2026
1. SHIN J, Yoo J, Gu K, Baek SY, et al
   Evaluating Accuracy of LI-RADS Nonradiation Treatment Response Algorithm v2024 and Ancillary Features at Hepatobiliary MRI versus CT.
   Radiology. 2026;319:e253143.
   PubMed     Abstract available
   
   
   May 2026
2. BERMAN ZT, De la Garza-Ramos C, Montazeri SA, Malone CD, et al
   Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma.
   Radiology. 2026;319:e251923.
   PubMed     Abstract available
   
   
   
3. BRUNSING RL, Syed AB, Hargreaves BA, Ennis DB, et al
   Diffusion-weighted Imaging of the Liver: Primed for New Business.
   Radiology. 2026;319:e250157.
   PubMed     Abstract available
   
   
   
4. WANG TC, Wei N, Bao Y, Li JX, et al
   CT Radiomics-based Machine Learning to Identify Intratumoral Fibrosis and Underlying Angiogenesis in Hepatocellular Carcinoma.
   Radiology. 2026;319:e250736.
   PubMed     Abstract available
   
   
   
5. MITTELSTEIN DR, Khurana A, Vodkin I, Vavinskaya V, et al
   Interobserver Agreement in Contrast-enhanced US for Hepatic Nodules in Patients with Fontan-associated Liver Disease.
   Radiology. 2026;319:e252622.
   PubMed     Abstract available
   
   
   April 2026
6. MENG F, Teng Y
   Abernethy Malformation Type I with Multiple Hepatic FNH/NRH.
   Radiology. 2026;319:e252981.
   PubMed    
   
   
   March 2026
7. CHOI ES, Koo B, Kim S, Song IH, et al
   MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller.
   Radiology. 2026;318:e252611.
   PubMed     Abstract available
   
   
   
8. LI Y, Lu S, Mao S, Li Q, et al
   Contrast-Enhanced US Using Perfluorobutane for Diagnosing Small HCC in High-Risk Patients: Comparison with MRI LI-RADS Version 2018.
   Radiology. 2026;318:e252271.
   PubMed     Abstract available
   
   
   
9. KUHNEL C, Schmidt TN, Freesmeyer M, Schricke M, et al
   Transarterial Radioembolization: Medical Staff Dosimetry for (90)Y-Resin, (90)Y-Glass, and (166)Ho-PLLA Microspheres.
   Radiology. 2026;318:e251822.
   PubMed     Abstract available
   
   
   
10. DOPPELT G, Occean BV, Fabbro-Peray P, Haefliger L, et al
    The Safety Standards for Liver Percutaneous Thermal Ablation: A Meta-Analysis of Adverse Events over 15 Years.
    Radiology. 2026;318:e251517.
    PubMed     Abstract available
    
    
    
11. DIMOPOULOS MP, Sotirchos VS, Vakiani E, Sigel C, et al
    Optimizing Colorectal Liver Metastasis Ablation through Metabolic Imaging, Margin Assessment, and Biopsy (The OPTABLATE Prospective Trial).
    Radiology. 2026;318:e250864.
    PubMed     Abstract available
    
    
    
12. CENTNER CS, Choi R, Georgiades CS, Yarchoan M, et al
    Thermal and Nonthermal Liver Ablation: Mechanistic Foundations, Clinical Implementation, Immunologic Trial Design, and Artificial Intelligence.
    Radiology. 2026;318:e250263.
    PubMed     Abstract available
    
    
    
13. CHO SH, Jung YJ, Hong SB, Choi SJ, et al
    Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.
    Radiology. 2026;318:e252892.
    PubMed     Abstract available
    
    
    February 2026
14. QI BN, Zhao XY, Lv WJ, Shan S, et al
    Nodular Transformation-driven Circulatory Remodeling in Biliary Atresia-induced Pediatric Biliary Cirrhosis: A Three-dimensional Phase-Contrast CT Rendering.
    Radiology. 2026;318:e252332.
    PubMed     Abstract available
    
    
    
15. LEWIS S, Wildman-Tobriner B, Cuevas J, Calle S, et al
    Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis.
    Radiology. 2026;318:e251497.
    PubMed     Abstract available
    
    
    
16. KIM TH, Harding JJ, Chernyak V, Mendiratta-Lala M, et al
    How I Do It: Systemic Therapies for Primary Liver Cancers.
    Radiology. 2026;318:e251371.
    PubMed     Abstract available
    
    
    January 2026
17. GEORGIADES C
    Intrahepatic Cholangiocarcinoma: Local-Regional Therapies Join the Fight.
    Radiology. 2026;318:e253806.
    PubMed    
    
    
    
18. CHEN S, Qi H, Shen L, Lin L, et al
    Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2026;318:e252521.
    PubMed    
    
    
    
19. PANG C, Li J, An C, Wang Z, et al
    Survival Outcomes of Microwave Ablation Compared with Repeat Liver Resection in the Treatment of Recurrent Intrahepatic Cholangiocarcinoma.
    Radiology. 2026;318:e243254.
    PubMed     Abstract available
    
    
    
20. CHENG MQ, Hu HT, Wu SH, Huang H, et al
    Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance.
    Radiology. 2026;318:e252252.
    PubMed     Abstract available
    
    
    
21. DAGGUMATI L, Stark L, Booth AL, Fraum TJ, et al
    Case 344: Hepatic Epithelioid Hemangioendothelioma.
    Radiology. 2026;318:e251815.
    PubMed     Abstract available
    
    
    
22. MATTEINI F, Vilgrain V
    Isolated Hepatic Mucormycosis in Acute Lymphoblastic Leukemia.
    Radiology. 2026;318:e252306.
    PubMed    
    
    
    December 2025
23. ZHU L, Jiang B, Fei X, Xu Y, et al
    Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy.
    Radiology. 2025;317:e251698.
    PubMed     Abstract available
    
    
    
24. XIAO Z, Liu X
    Hepatocellular Carcinoma Presenting as Bile Duct Tumor Thrombus without Obvious Intrahepatic Mass.
    Radiology. 2025;317:e251418.
    PubMed    
    
    
    November 2025
25. YU SCH, Chan L, Lee KF, Cho CCM, et al
    Ethiodized Oil-based Transarterial Chemoembolization for Hepatocellular Carcinoma: Randomized Clinical Trial of Anhydrous Cisplatin Suspension versus Cisplatin Emulsion.
    Radiology. 2025;317:e242982.
    PubMed     Abstract available
    
    
    
26. PARK R, Choi ES, Byun JH, Won HJ, et al
    Diagnostic Value of Precontrast Low Attenuation as a LI-RADS CT Ancillary Feature for Hepatocellular Carcinoma.
    Radiology. 2025;317:e251598.
    PubMed     Abstract available
    
    
    October 2025
27. DENG M, Li Z, Sun L, Wang H, et al
    Liver MRI-derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study.
    Radiology. 2025;317:e250026.
    PubMed     Abstract available
    
    
    
28. FOWLKES JB
    Microbubbles, Ultrasound, and Radiation: Finding the Treatment Synergy for Hepatocellular Carcinoma.
    Radiology. 2025;317:e252815.
    PubMed    
    
    
    September 2025
29. WESSNER CE, Forsberg F, Lyshchik A, O'Kane P, et al
    Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial.
    Radiology. 2025;316:e250083.
    PubMed     Abstract available
    
    
    August 2025
30. CANNELLA R
    MRI Quantitative Features: A Bridge to Hepatocellular Carcinoma Tumor Profiling.
    Radiology. 2025;316:e252216.
    PubMed     Abstract available
    
    
    
31. MATUSCHEWSKI NJ, Sobirey R, Revzin M, Zeevi T, et al
    Noninvasive Tumor Profiling: Quantitative Contrast-Enhanced MRI Markers Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2025;316:e242750.
    PubMed     Abstract available
    
    
    
32. XIA H, Min Y, Wang Y, Gao S, et al
    Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet-induced Mouse Model.
    Radiology. 2025;316:e243780.
    PubMed     Abstract available
    
    
    July 2025
33. ABEDRABBO N, Lam ET, McInnes MDF, Dawit H, et al
    Impact of LI-RADS CT and MRI Ancillary Features on Diagnostic Performance: An Individual Participant Data Meta-Analysis.
    Radiology. 2025;316:e242278.
    PubMed     Abstract available
    
    
    
34. LEWANDOWSKI RJ, Serhal M, Padia SA, Kim E, et al
    The Evolving Application of Radiation Segmentectomy for the Treatment of Hepatic Malignancy.
    Radiology. 2025;316:e240333.
    PubMed     Abstract available
    
    
    
35. HUANG TY, Li ZY, Tian J, Xie XJ, et al
    Metabolic Dysfunction-Associated Steatotic Liver Disease at Quantitative US: International Prospective Study.
    Radiology. 2025;316:e242564.
    PubMed     Abstract available
    
    
    
36. ZHANG W, Shen G
    Hepatic Langerhans Cell Histiocytosis Revealed at FAPI PET/CT.
    Radiology. 2025;316:e243458.
    PubMed    
    
    
    
37. REA B, Blakeborough A
    Case 339: Hepatobiliary Contrast Agent Uptake in an Adrenal Metastasis from Hepatocellular Carcinoma.
    Radiology. 2025;316:e242718.
    PubMed     Abstract available
    
    
    June 2025
38. ADAMO RG, van der Pol CB, Alabousi M, Lam E, et al
    Diagnostic Performance of CT/MRI LI-RADS Version 2018 Major Feature Combinations: Individual Participant Data Meta-Analysis.
    Radiology. 2025;315:e243450.
    PubMed     Abstract available
    
    
    May 2025
39. LIU H, Fan W, Li H, Qiao L, et al
    Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial.
    Radiology. 2025;315:e242315.
    PubMed     Abstract available
    
    
    April 2025
40. WU H, Zhu Z, Li J, Qiu C, et al
    Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression.
    Radiology. 2025;315:e242349.
    PubMed     Abstract available
    
    
    
41. QIU C
    US Markers for Differentiating Hepatic Inflammation in Chronic Liver Disease: Still a Long Way to Go.
    Radiology. 2025;315:e242559.
    PubMed    
    
    
    
42. GUO X, Zhou Y
    Agenesis of the Intrahepatic Inferior Vena Cava with Pulmonary Venous Fistula.
    Radiology. 2025;315:e242069.
    PubMed    
    
    
    March 2025
43. LEE S, Yoon JK, Shin J, Shin H, et al
    US Liver Imaging Reporting and Data System Version 2017: A Systematic Review and Meta-Analysis.
    Radiology. 2025;314:e240450.
    PubMed     Abstract available
    
    
    
44. DELL T, Mesropyan N, Layer Y, Tischler V, et al
    Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study.
    Radiology. 2025;314:e241677.
    PubMed     Abstract available
    
    
    
45. REA B, Blakeborough A
    Case 339.
    Radiology. 2025;314:e242717.
    PubMed     Abstract available
    
    
    
46. AN J, Park R, Kim E, Na SK, et al
    LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C.
    Radiology. 2025;314:e241856.
    PubMed     Abstract available
    
    
    
47. SCHOLLNAST H
    Imaging-based Hepatocellular Carcinoma Diagnosis: An Extension of LI-RADS to Patients with Noncirrhotic Hepatitis C.
    Radiology. 2025;314:e250627.
    PubMed    
    
    
    February 2025
48. ZHANG YJ, Chen J, Zhou Z, Hu D, et al
    Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.
    Radiology. 2025;314:e241096.
    PubMed     Abstract available
    
    
    
49. ZHANG K, He K, Zhang L, Li WC, et al
    Gadoxetic Acid-enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular Carcinoma.
    Radiology. 2025;314:e233229.
    PubMed     Abstract available
    
    
    
50. RONOT M
    Advancing Care: Managing Small Late-Recurrence Hepatocellular Carcinoma with Image-guided Therapy.
    Radiology. 2025;314:e243768.
    PubMed    
    
    
    
51. BITAR R, Salem R, Finn R, Greten TF, et al
    Erratum for: Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2025;314:e259004.
    PubMed    
    
    
    January 2025
52. WILDMAN-TOBRINER B, Felice N, Kalisz KR, Allen BC, et al
    Photon-Counting CT Effects on Sensitivity for Liver Lesion Detection: A Reader Study Using Virtual Imaging.
    Radiology. 2025;314:e241568.
    PubMed     Abstract available
    
    
    
53. LYSHCHIK A, Kuon Yeng Escalante C, Siu Xiao T, Piscaglia F, et al
    Contrast-enhanced US of High-Risk Indeterminate Focal Liver Observations Categorized as LR-4 or LR-M at CT/MRI.
    Radiology. 2025;314:e240916.
    PubMed     Abstract available
    
    
    
54. LI W, Lv J, Li H, Song L, et al
    Quantification of Vascular Remodeling and Sinusoidal Capillarization to Assess Liver Fibrosis with Photoacoustic Imaging.
    Radiology. 2025;314:e241275.
    PubMed     Abstract available
    
    
    December 2024
55. KAMAYA A, Fetzer DT, Seow JH, Burrowes DP, et al
    LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of Radiology US LI-RADS.
    Radiology. 2024;313:e240169.
    PubMed     Abstract available
    
    
    
56. JANG HJ, Choi SH, Wee S, Choi SJ, et al
    CT- and MRI-based Factors Associated with Rapid Growth in Early-Stage Hepatocellular Carcinoma.
    Radiology. 2024;313:e240961.
    PubMed     Abstract available
    
    
    November 2024
57. HAGHSHOMAR M, Antonacci D, Smith AD, Thaker S, et al
    Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis.
    Radiology. 2024;313:e241171.
    PubMed     Abstract available
    
    
    
58. JIANG H, Cannella R, Wu Z, Beaufrere A, et al
    Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study.
    Radiology. 2024;313:e233471.
    PubMed     Abstract available
    
    
    
59. HARMATH C
    Hepatocellular Carcinoma: The Meaning of Intratumoral Fat Patterns in Different Patient Populations.
    Radiology. 2024;313:e242740.
    PubMed    
    
    
    
60. LAI B, Zhong J
    Hepatic Langerhans Cell Histiocytosis.
    Radiology. 2024;313:e241037.
    PubMed    
    
    
    
61. ASLAM A, Chernyak V, Miller FH, Bashir M, et al
    CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.
    Radiology. 2024;313:e232408.
    PubMed     Abstract available
    
    
    
62. BITAR R, Salem R, Finn R, Greten TF, et al
    Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2024;313:e232875.
    PubMed     Abstract available
    
    
    October 2024
63. RIEDEL C, Hoffmann M, Ismahil M, Lenz A, et al
    Four-dimensional Flow MRI-based Computational Fluid Dynamics Simulation for Noninvasive Portosystemic Pressure Gradient Assessment in Patients with Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt.
    Radiology. 2024;313:e232989.
    PubMed     Abstract available
    
    
    
64. MATOS C, Metens T
    Liver Fibrosis: Diving into Microstructure with Diffusion-weighted Imaging.
    Radiology. 2024;313:e242548.
    PubMed    
    
    
    
65. ZHANG L, Long X, Chen L, Han X, et al
    Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI.
    Radiology. 2024;313:e240343.
    PubMed     Abstract available
    
    
    
66. CAO J, Mroueh N, Mercaldo N, Lennartz S, et al
    Detectability of Hypoattenuating Liver Lesions with Deep Learning CT Reconstruction: A Phantom and Patient Study.
    Radiology. 2024;313:e232749.
    PubMed     Abstract available
    
    
    
67. MOTOSUGI U, Watanabe H
    Navigating Hemodynamic Insights: A Promising Future with Four-dimensional Flow MRI and Computational Fluid Dynamics in Transjugular Intrahepatic Portosystemic Shunt Management.
    Radiology. 2024;313:e241857.
    PubMed    
    
    
    
68. FERRAIOLI G, Roccarina D, Barr RG
    Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis.
    Radiology. 2024;313:e240162.
    PubMed     Abstract available
    
    
    September 2024
69. MENDIRATTA-LALA M, Wiggermann P, Pech M, Serres-Creixams X, et al
    The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors.
    Radiology. 2024;312:e233051.
    PubMed     Abstract available
    
    
    
70. PIERCE TT, Ozturk A, Sherlock SP, Moura Cunha G, et al
    Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease.
    Radiology. 2024;312:e233094.
    PubMed     Abstract available
    
    
    
71. AHMED TM, Fishman EK
    Cinematic Rendering of Hepatic Hydatid Disease.
    Radiology. 2024;312:e240527.
    PubMed    
    
    
    
72. WILDMAN-TOBRINER B
    Photon-counting Detector CT: A Promising Tool for Noninvasive Liver Fat Assessment.
    Radiology. 2024;312:e241963.
    PubMed    
    
    
    
73. LIN H, Xu X, Deng R, Xu Z, et al
    Photon-counting Detector CT for Liver Fat Quantification: Validation across Protocols in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e240038.
    PubMed     Abstract available
    
    
    August 2024
74. SUGIMOTO K, Moriyasu F, Dioguardi Burgio M, Vilgrain V, et al
    US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study.
    Radiology. 2024;312:e233377.
    PubMed     Abstract available
    
    
    
75. YIN M
    Shear-Wave Dispersion for Detecting Hepatic Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e241420.
    PubMed    
    
    
    
76. CHEUNG CL, Tripathi V, Chiang CL, Chiu KWH, et al
    Impact of Hepatocellular Carcinoma Etiology on the Performance of LI-RADS LR5.
    Radiology. 2024;312:e240056.
    PubMed    
    
    
    June 2024
77. KIM PH, Hwang JY, Choi YH, Yoon HM, et al
    Safety of Gadoxetate Disodium for Hepatobiliary MRI in Children and Adolescents.
    Radiology. 2024;311:e232462.
    PubMed     Abstract available
    
    
    
78. OTERO HJ
    Gadoxetate Disodium Hepatobiliary Contrast Material Is Safe in Children and Adolescents.
    Radiology. 2024;311:e241082.
    PubMed    
    
    
    May 2024
79. SARWAR A, Malik MS, Vo NH, Tsai LL, et al
    Efficacy and Safety of Radiation Segmentectomy with (90)Y Resin Microspheres for Hepatocellular Carcinoma.
    Radiology. 2024;311:e231386.
    PubMed     Abstract available
    
    
    
80. MENDIRATTA-LALA M, Fetzer D, Kamaya A, Parikh ND, et al
    The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Radiology. 2024;311:e232624.
    PubMed     Abstract available
    
    
    
81. OZKAYA E, Kennedy P, Chen J, Bane O, et al
    Precision and Test-Retest Repeatability of Stiffness Measurement with MR Elastography: A Multicenter Phantom Study.
    Radiology. 2024;311:e233136.
    PubMed     Abstract available
    
    
    
82. TANG A
    Liver Stiffness at MR Elastography: A Surrogate Biomarker for Staging Liver Fibrosis, Predicting Clinical Outcomes, and Selecting Patients.
    Radiology. 2024;311:e240890.
    PubMed    
    
    
    
83. MILOT L
    Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e240124.
    PubMed    
    
    
    
84. LYSHCHIK A, Fetzer DT, Kono Y, Wilson SR, et al
    Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e232369.
    PubMed     Abstract available
    
    
    April 2024
85. YOON JH, Kim YK, Kim JW, Chang W, et al
    Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
    Radiology. 2024;311:e233114.
    PubMed     Abstract available
    
    
    
86. LEE Y, Kim NH, Kang JH, Cho YS, et al
    Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
    Radiology. 2024;311:e232188.
    PubMed     Abstract available
    
    
    
87. LYU L, Xu P
    Hepatic CT Perfusion in Budd-Chiari Syndrome before and after Intervention.
    Radiology. 2024;311:e232426.
    PubMed    
    
    
    
88. GHOSH A
    B-mode US and Deep Learning Rivals Shear-Wave Elastography in Screening for Fibrosis.
    Radiology. 2024;311:e240868.
    PubMed    
    
    
    
89. ZENG QQ, Liang P
    Super-Resolution US Imaging of Focal Nodular Hyperplasia.
    Radiology. 2024;311:e233130.
    PubMed    
    
    
    
90. CHEN LD, Huang ZR, Yang H, Cheng MQ, et al
    US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening.
    Radiology. 2024;311:e231461.
    PubMed     Abstract available
    
    
    March 2024
91. MOURA CUNHA G, Fan B, Navin PJ, Olivie D, et al
    Interpretation, Reporting, and Clinical Applications of Liver MR Elastography.
    Radiology. 2024;310:e231220.
    PubMed     Abstract available
    
    
    
92. LIU F, Bi M, Jing X, Ding H, et al
    Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
    Radiology. 2024;310:e232416.
    PubMed     Abstract available
    
    
    
93. REUTER KL
    Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
    Radiology. 2024;310:e240436.
    PubMed    
    
    
    February 2024
94. CHAPIRO J
    Image-guided High-Dose-Rate Brachytherapy for Hepatocellular Carcinoma Could Be the Ultimate Ablation Tool.
    Radiology. 2024;310:e240072.
    PubMed    
    
    
    
95. AUER TA, Muller L, Schulze D, Anhamm M, et al
    CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
    Radiology. 2024;310:e232044.
    PubMed     Abstract available
    
    
    
96. SHEWAREGA A, Santana JG, Nam D, Berz A, et al
    Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8(+) T-Cell Infiltration in Murine Hepatocellular Carcinoma.
    Radiology. 2024;310:e232365.
    PubMed     Abstract available
    
    
    
97. GEMMETE JJ
    Partial Cryoablation and Matrix Metalloproteinase Inhibition May Be a Possible Treatment Option for Hepatocellular Carcinoma.
    Radiology. 2024;310:e240015.
    PubMed    
    
    
    
98. CRIVELLARO P
    A Deeper Look into Ancillary Features in LI-RADS Classification.
    Radiology. 2024;310:e240251.
    PubMed    
    
    
    
99. DAWIT H, Lam E, McInnes MDF, van der Pol CB, et al
    LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma and Malignancy: An Individual Participant Data Meta-Analysis.
    Radiology. 2024;310:e231501.
    PubMed     Abstract available
    
    
    
100. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
     Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
     Radiology. 2024;310:e231160.
     PubMed     Abstract available
     
     
     
101. KARTALIS N, Grigoriadis A
     LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
     Radiology. 2024;310:e240161.
     PubMed    
     
     
     January 2024
102. MA L, Zhang W, Ma J, Luo J, et al
     Transjugular Intrahepatic Portosystemic Shunt versus Endoscopy with Drug Therapy Warrants Further Exploration.
     Radiology. 2024;310:e232499.
     PubMed    
     
     
     
103. TAN XZ, Chen X, Liu P
     Potential Influence of Inconsistent Arterial Phase Imaging on Macrotrabecular-massive Hepatocellular Carcinoma Prediction.
     Radiology. 2024;310:e232349.
     PubMed    
     
     
     
104. KADI D, Loomba R, Bashir MR
     Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions.
     Radiology. 2024;310:e222695.
     PubMed     Abstract available
     
     
     
105. FOWLER KJ, Chernyak V
     What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease.
     Radiology. 2024;310:e232771.
     PubMed    
     
     
     
106. DIETRICH CF
     Modified Algorithm for Contrast-enhanced US LI-RADS.
     Radiology. 2024;310:e232742.
     PubMed    
     
     
     December 2023
107. GOINS SM, Jiang H, van der Pol CB, Salameh JP, et al
     Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis.
     Radiology. 2023;309:e231656.
     PubMed     Abstract available
     
     
     
108. SIRLIN CB, Chernyak V
     Are We Ready to Simplify and Improve LI-RADS?
     Radiology. 2023;309:e233164.
     PubMed    
     
     
     
109. TAMIR S, Tau N
     Hepatocellular Carcinoma and Pretransplant Liver Imaging: Benefits of Per-patient Assessment.
     Radiology. 2023;309:e233123.
     PubMed    
     
     
     
110. HASSAN OT, Behr SC, Ohliger MA, Fowler KJ, et al
     Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
     Radiology. 2023;309:e222776.
     PubMed     Abstract available
     
     
     November 2023
111. JIANG H, Yang C, Chen Y, Wang Y, et al
     Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
     Radiology. 2023;309:e230527.
     PubMed     Abstract available
     
     
     
112. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
     Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
     Radiology. 2023;309:e222891.
     PubMed     Abstract available
     
     
     
113. TSAI R, Mellnick VM
     Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
     Radiology. 2023;309:e232480.
     PubMed    
     
     
     
114. OZTURK A, Kumar V, Pierce TT, Li Q, et al
     The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
     Radiology. 2023;309:e223146.
     PubMed     Abstract available
     
     
     
115. TAN XZ, Liu P, Xiang H
     The Influence of Single Arterial Phase Imaging on Prediction of Microvascular Invasion of Hepatocellular Carcinoma.
     Radiology. 2023;309:e231141.
     PubMed    
     
     
     October 2023
116. TUTHILL TA
     Advancing AI-assisted US Screening for Fatty Liver.
     Radiology. 2023;309:e232442.
     PubMed    
     
     
     
117. HAN A
     Hepatic Steatosis Assessment: Harnessing the Power of Integrating Multiple Quantitative US Parameters.
     Radiology. 2023;309:e232475.
     PubMed    
     
     
     
118. VIANNA P, Calce SI, Boustros P, Larocque-Rigney C, et al
     Comparison of Radiologists and Deep Learning for US Grading of Hepatic Steatosis.
     Radiology. 2023;309:e230659.
     PubMed     Abstract available
     
     
     
119. KURODA H, Oguri T, Kamiyama N, Toyoda H, et al
     Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
     Radiology. 2023;309:e230341.
     PubMed     Abstract available
     
     
     
120. SAVSANI E, Shaw CM, Forsberg F, Wessner CE, et al
     Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
     Radiology. 2023;309:e230727.
     PubMed     Abstract available
     
     
     
121. HEO S, Lee SS, Choi SH, Kim DW, et al
     CT Rule-in and Rule-out Criteria for Clinically Significant Portal Hypertension in Chronic Liver Disease.
     Radiology. 2023;309:e231208.
     PubMed     Abstract available
     
     
     
122. FRAUM TJ
     CT-based Diagnosis of Clinically Significant Portal Hypertension: An Opportunity to Prevent Complications.
     Radiology. 2023;309:e232439.
     PubMed    
     
     
     
123. XIA T, Du M, Li H, Wang Y, et al
     Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
     Radiology. 2023;309:e231007.
     PubMed     Abstract available
     
     
     
124. REEDER SB, Starekova J
     MRI Proton Density Fat Fraction for Liver Disease Risk Assessment: A Call for Clinical Implementation.
     Radiology. 2023;309:e232552.
     PubMed    
     
     
     
125. MONSELL SE
     Statistical Methods for Exploring Causal Relationships between Risk Factors and Liver Disease.
     Radiology. 2023;309:e232551.
     PubMed    
     
     
     
126. FOWLER KJ, Venkatesh SK, Obuchowski N, Middleton MS, et al
     Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
     Radiology. 2023;309:e231092.
     PubMed     Abstract available
     
     
     
127. KOZAKA K, Matsui O
     MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease.
     Radiology. 2023;309:e232420.
     PubMed    
     
     
     September 2023
128. HYODO R, Takehara Y, Mizuno T, Ichikawa K, et al
     Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization.
     Radiology. 2023;308:e230709.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum